Botulinum toxin A - Lipella Pharmaceuticals

Drug Profile

Botulinum toxin A - Lipella Pharmaceuticals

Alternative Names: Liposomal botulinum toxin A - Lipella Pharmaceuticals; LP-09

Latest Information Update: 29 Dec 2014

Price : $50

At a glance

  • Originator Lipella Pharmaceuticals
  • Class Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Muscle relaxants
  • Mechanism of Action Acetylcholine inhibitors; Glutamate-antagonists; Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Interstitial cystitis; Overactive bladder

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 01 May 2010 Phase-II clinical trials in Overactive bladder (treatment-resistant) in Taiwan (Intravesicular)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top